| Jul 11 |
Institutional investors have a lot riding on Relmada Therapeutics, Inc. (NASDAQ:RLMD) with 48% ownership
|
| Jun 18 |
Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry
|
| Jun 10 |
Relmada Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
|
| Jun 5 |
Keurig Dr Pepper To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
|
| Jun 3 |
Relmada Therapeutics to Participate in the 2024 Jefferies Global Healthcare Conference
|
| May 28 |
7 Penny Biotech Stocks to Triple Your Investment
|
